750 related articles for article (PubMed ID: 17619301)
1. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
Vacek J; Klejdus B; Kubán V
Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
[TBL] [Abstract][Full Text] [Related]
2. St. John's wort: role of active compounds for its mechanism of action and efficacy.
Butterweck V; Schmidt M
Wien Med Wochenschr; 2007; 157(13-14):356-61. PubMed ID: 17704987
[TBL] [Abstract][Full Text] [Related]
3. St. John's wort.
Lawvere S; Mahoney MC
Am Fam Physician; 2005 Dec; 72(11):2249-54. PubMed ID: 16342849
[TBL] [Abstract][Full Text] [Related]
4. The main components of St John's Wort inhibit low-density lipoprotein atherogenic modification: a beneficial "side effect" of an OTC antidepressant drug?
Laggner H; Schreier S; Hermann M; Exner M; Mühl A; Gmeiner BM; Kapiotis S
Free Radic Res; 2007 Feb; 41(2):234-41. PubMed ID: 17364950
[TBL] [Abstract][Full Text] [Related]
5. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377
[TBL] [Abstract][Full Text] [Related]
6. Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models.
Butterweck V; Christoffel V; Nahrstedt A; Petereit F; Spengler B; Winterhoff H
Life Sci; 2003 Jun; 73(5):627-39. PubMed ID: 12770617
[TBL] [Abstract][Full Text] [Related]
7. Topical anti-inflammatory activity of extracts and compounds from Hypericum perforatum L.
Sosa S; Pace R; Bornancin A; Morazzoni P; Riva A; Tubaro A; Della Loggia R
J Pharm Pharmacol; 2007 May; 59(5):703-9. PubMed ID: 17524236
[TBL] [Abstract][Full Text] [Related]
8. Determining hyperforin and hypericin content in eight brands of St. John's wort.
de los Reyes GC; Koda RT
Am J Health Syst Pharm; 2002 Mar; 59(6):545-7. PubMed ID: 11908248
[No Abstract] [Full Text] [Related]
9. Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients.
Wurglics M; Schubert-Zsilavecz M
Clin Pharmacokinet; 2006; 45(5):449-68. PubMed ID: 16640452
[TBL] [Abstract][Full Text] [Related]
10. Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis.
Ng QX; Venkatanarayanan N; Ho CY
J Affect Disord; 2017 Mar; 210():211-221. PubMed ID: 28064110
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of total hypericin and hyperforin in St. John's wort extracts by HPLC with electrochemical detection.
Rückert U; Likussar W; Michelitsch A
Phytochem Anal; 2007; 18(3):204-8. PubMed ID: 17500362
[TBL] [Abstract][Full Text] [Related]
12. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.
Laakmann G; Schüle C; Baghai T; Kieser M
Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():54-9. PubMed ID: 9684948
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant activity of hyperforin conjugates of the St. John's wort, Hypericum perforatum Linn.: an experimental study.
Muruganandam AV; Bhattacharya SK; Ghosal S
Indian J Exp Biol; 2001 Dec; 39(12):1302-4. PubMed ID: 12018529
[TBL] [Abstract][Full Text] [Related]
14. Role of hyperforin in the pharmacological activities of St. John's Wort.
Zanoli P
CNS Drug Rev; 2004; 10(3):203-18. PubMed ID: 15492771
[TBL] [Abstract][Full Text] [Related]
15. Lessons learned from herbal medicinal products: the example of St. John's Wort (perpendicular).
Nahrstedt A; Butterweck V
J Nat Prod; 2010 May; 73(5):1015-21. PubMed ID: 20408551
[TBL] [Abstract][Full Text] [Related]
16. [Cellular and molecular effects of the antidepressant hyperforin on brain cells: Review of the literature].
Bouron A; Lorrain E
Encephale; 2014 Apr; 40(2):108-13. PubMed ID: 23816060
[TBL] [Abstract][Full Text] [Related]
17. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).
Dimpfel W; Schober F; Mannel M
Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():30-5. PubMed ID: 9684945
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression.
Obach RS
J Pharmacol Exp Ther; 2000 Jul; 294(1):88-95. PubMed ID: 10871299
[TBL] [Abstract][Full Text] [Related]
19. The Biochemical and Genetic Basis for the Biosynthesis of Bioactive Compounds in
Rizzo P; Altschmied L; Ravindran BM; Rutten T; D'Auria JC
Genes (Basel); 2020 Oct; 11(10):. PubMed ID: 33081197
[No Abstract] [Full Text] [Related]
20. Effects of St John's wort and its active constituents, hypericin and hyperforin, on isolated rat urinary bladder.
Valeri A; Capasso R; Valoti M; Pessina F
J Pharm Pharmacol; 2012 Dec; 64(12):1770-6. PubMed ID: 23146040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]